Natural supplements for improving insulin sensitivity and glucose uptake in skeletal muscle

Frontiers in Bioscience - Elite

Volumn 7E, Issue 1, 2015, Pages 107-121

  Kouzi, Samir A ^a   Yang, Sendra ^a   Nuzum, Donald S ^a   Dirks Naylor, Amie J ^a  

^a WINGATE UNIVERSITY   (United States)

Author keywords

Dietary supplements; Insulin resistance; Natural products; Review; Skeletal muscle; Type 2 diabetes mellitus

Indexed keywords

BIOTIN; GLUCOSE; INSULIN; NATURAL PRODUCT; THIOCTIC ACID; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B BETA; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CINNAMON; DIET SUPPLEMENTATION; FENUGREEK; GINSENG; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; INSULIN TREATMENT; LAGERSTROEMIA; LAGERSTROEMIA SPECIOSA; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKELETAL MUSCLE; SYSTEMATIC REVIEW (TOPIC); GLUCOSE BLOOD LEVEL; MOLECULARLY TARGETED THERAPY;

CINNAMOMUM VERUM; PANAX GINSENG; TRIGONELLA FOENUM-GRAECUM;

EID: 84918775925     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/E720     Document Type: Article

References (94)

1. S. Wild, G. Roglic, A. Green, R. Sicree, H. King: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004) DOI: 10.2337/diacare.27.5.1047
2. K. Kaul, J.M. Tarr, S.I. Ahmad, E.M. Kohner, R. Chibber. Introduction to diabetes mellitus. In: Diabetes - An Old Disease, A New Insight (Springer Series: Advances in Experimental Medicine and Biology). Ed: SI Ahmad. Landes Bioscience/Springer Science + Business Media, LLC, New York, New York, Vol. 771, 1-11 (2012)
3. N.H. McClenaghan: Physiological regulation of the pancreatic beta-cell: functional insights for understanding and therapy of diabetes. Exp Physiol 92, 481-496 (2007) DOI: 10.1113/expphysiol.2006.034835
4. M. Stumvoll, B.J. Goldstein, T.W. Van Haeften: Pathogenesis of type 2 diabetes. Endocr Res 32, 19-37 (2007) DOI: 10.1080/07435800701743810
5. H.N. Ginsberg: Insulin resistance and cardiovascular disease. J Clin Invest 106, 453-458 (2000) DOI: 10.1172/JCI10762
6. G.I. Shulman: Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176 (2000) DOI: 10.1172/JCI10583
7. G. Murdolo, U. Smith: The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis 16, S35-S38 (2006) DOI: 10.1016/j.numecd.2005.10.016
8. R.A. DeFronzo: Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. Diabetologia 53, 1270-1287 (2009) DOI: 10.1007/s00125-010-1684-1
9. J.E. Pessin, A.R. Saltiel: Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106, 165-169 (2000) DOI: 10.1172/JCI10582
10. A.J. Krentz, C.J. Bailey: Oral antidiabetic agents - current role in type 2 diabetes mellitus. Drugs 65, 385-411 (2005) DOI: 10.2165/00003495-200565030-00005
11. D.S.H. Bell: Type 2 diabetes mellitus: what is the optimal treatment regimen?. Am J Med 116, 23S-29S (2004) DOI: 10.1016/j.amjmed.2003.10.017
12. M. Stumvoll, B.J. Goldstein, T.W. Van Haeften: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346 (2005) DOI: 10.1016/S0140-6736(05)61032-X
13. R.H. Eckel, S.M. Grundy, P.Z. Zimmet: The metabolic syndrome. Lancet 365, 1415-1428 (2005) DOI: 10.1016/S0140-6736(05)66378-7
14. M.O. Larsen: Beta-cell function and mass in type 2 diabetes. Dan Med Bull 56, 153-164 (2009)
15. C.J. Rhodes: Type 2 diabetes - a matter of beta-cell life and death?. Science 307, 380-384 (2005) DOI: 10.1126/science.1104345
16. L.E. Egede, X. Ye, D. Zheng, M.D. Silverstein: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25, 324-329 (2002) DOI: 10.2337/diacare.25.2.324
17. S.S. Handa, A.S. Chawla: Hypoglycemic plants: a review. Fitoterapia 9, 195-224 (1989)
18. R. Marles, N.R. Farnsworth: Antidiabetic plants and their active constituents. Phytomedicine 2, 137-189 (1995) DOI: 10.1016/S0944-7113(11)80059-0
19. S.S. Ajgaonkar: Herbal drugs in the treatment of diabetes: a review. IDF Bull 24, 10-17 (1979)
20. G.Y. Yeh, D.M. Eisenberg, T.J. Kaptchuk, R.S. Phillips: Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26, 1277-1294 (2003) DOI: 10.2337/diacare.26.4.1277
21. R.A. DeFronzo, D. Tripathy: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32, S157-S163 (2009) DOI: 10.2337/dc09-S302
22. V.T. Samuel, G.I. Shulman: Integrating mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871 (2012) DOI: 10.1016/j.cell.2012.02.017
23. N. Musi, L.J. Goodyear: Insulin resistance and improvements in signal transduction. Endocrine 29, 73-80 (2006) DOI: 10.1385/ENDO:29:1:73
24. B. Viollet, R. Mounier, J. Leclerc, A. Yazigi, M. Foretz, F. Andreelli: Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab 33, 395-402 (2007) DOI: 10.1016/j.diabet.2007.10.004
25. C. Orwa, A. Mutua, R. Kindt, R. Jamnadass, A. Simons: Agroforestree Database: a tree reference and selection guide version 4.0. (2009)
26. S. Stohs, H. Miller, G. Kaats: A review of the efficacy and safety of banaba and corosolic acid. Phytother Res 26, 317-324 (2012)
27. C. Murakami, K. Myoga, R. Kasai, K. Ohtani, T. Kurokawa, S. Ishibashi, F. Dayrit, W. Padolina, K. Tamaski: Screening of plant constituents for effect on glucose transport activity in ehrlich ascites tumor cells. Chem Pharm Bull 41, 2129-2131 (1993) DOI: 10.1248/cpb.41.2129
28. T. Miura, Y. Itoh, T. Kaneko, N. Ueda, T. Ishida, M. Fukushima, F. Matsuyama, Y. Seino: Corosolic acid induced GLUT4 translocation in genetically type 2 diabetic mice. Biol Pharm Bull 27, 1103-1105 (2004) DOI: 10.1248/bpb.27.1103
29. X. Liu, J. Kim, Y. Li, J. Li, F. Liu, X. Chen: Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 135, 165-171 (2005)
30. L. Shi, W. Zhang, Y. Zhou, Y. Zhang, J. Li, L. Hu, J. Li: Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol 584, 21-29 (2008) DOI: 10.1016/j.ejphar.2008.01.020
31. K. Yamada, M. Hosokawa, S. Fujimoto, H. Fujiwara, Y. Fujita, N. Harada, C. Yamada, M. Fukushima, N. Ueda, T. Kaneko, F. Matsuyama, Y. Yamada, Y. Seino, N. Inagaki: Effect of corosolic acid on gluconeogenesis in rat liver. Diabetes Res Clin Pract 80, 48-55 (2008) DOI: 10.1016/j.diabres.2007.11.011
32. W. Hou, Y. Li, Q. Zhang, X. Wei, A. Peng, L. Chen, Y. Wei: Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors. Phytother Res 23, 614-648 (2009) DOI: 10.1002/ptr.2661
33. Y. Ikeda, N. Noguchi, S. Kishi, K. Masuda, A. Kusumoto, M. Zeida, K. Abe, Y. Kiso: Blood glucose controlling effects and safety on single and long-term administration on the extract of Banaba leaves. J Nutr Food 5, 41-53 (2002)
34. W. Judy, S. Hari, W. Stogsdill, J. Judy, Y. Naguib, R. Passwater: Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in type II diabetics: a dose-dependence study. J Ethnopharmacol 87, 115-7 (2003) DOI: 10.1016/S0378-8741(03)00122-3
35. S. Rizvi, N. Mishra: Traditional Indian medicines used for the management of diabetes mellitus. J Diabetes Res 2013, 1-11 (2013)
36. V. Khan, A. Naijmi, M. Akhtar, M. Agil, M. Mujeeb, K. Pillai: A pharmacological appraisal of medicinal plants with antidiabetic potential. J Pharm Bioallied Sci 4, 27-42 (2012) DOI: 10.1016/j.jpba.2011.09.019
37. N. Jaiswal, C. Maurya, K. Venkateswarlu, P. Sukanya, A. Srivastava, T. Narender, A. Tamrakar: 4-Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells via phosphatidylinositol-3-kinase-dependent pathway. Eur J Nutr 51, 893-898 (2012) DOI: 10.1007/s00394-012-0374-9
38. S. Mohammad, A, Taha, K. Akhtar, R. Bamezai, N. Baquer: In vivo effect of Trigonella foenum graecum on the expression of pyruvate kinase, phosphoenolpyruvate carboxykinase, and distribution of glucose transporter (GLUT4) in alloxan-diabetic rats. Can J Physiol Pharmacol 84, 647-654 (2006) DOI: 10.1139/y05-164
39. K. Hamden, B. Jaouadi, S. Carreau, S. Bejar, A. Elfeki: Inhibitory effect of fenugreek galactomannan on digestive enzymes related to diabetes, hyperlipidemia, and liver dysfunctions. Biotechnol Bioprocess Eng 15, 407-413 (2010) DOI: 10.1007/s12257-009-3037-9
40. M. Vijayakumar, S. Signh, R. Chhipa, M. Bhat: The hypoglycemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signaling pathway. Br J Pharmacol 146, 41-48 (2005) DOI: 10.1038/sj.bjp.0706312
41. S. Haber, J. Keonavong: Fenugreek use in patients with diabetes mellitus. Am J Health-Syst Pharm 70, 1196-1203 (2013) DOI: 10.2146/ajhp120523
42. Z. Madar, R. Thorne: Dietary fiber. Prog Food Nutr Sci 11, 153-74 (1987)
43. A. Gupta, R. Gupta, B. Lal: Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India 49, 1057-61 (2001)
44. E. Basch, C. Ulbricht, G. Kuo, P. Szapary, M. Smith: Therapeutic applications of fenugreek. Altern Med Rev 8, 20-27 (2003)
45. J. Shergis, A. Zhang, W. Zhou, C. Xue: Panax ginseng in randomized controlled trials: a systematic review. Phytother Res 27, 949-965 (2013) DOI: 10.1002/ptr.4832
46. H. Lee, Y. Lee, S. Park, E. Kang, H. Kim, Y. Lee, C. Choi, S. Park, C. Ahn, B. Cha, K. Lee, K. Kim, S. Lim, H. Lee: Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism 58, 1170-1177 (2009) DOI: 10.1016/j.metabol.2009.03.015
47. H. Lee, O. Lee, K. Kim, B. Lee: Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathways in insulin-resistant muscle cells. Phytother Res 26, 1017-1022 (2012) DOI: 10.1002/ptr.3686
48. H. Kim, K. Kim: Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic beta-cell in the hypoglycemic effects of Korean red ginseng in Goto-Kakazaki rats. J Ethnopharmacol 142, 53-58 (2012) DOI: 10.1016/j.jep.2012.04.012
49. S. Sen, M. Querques, S. Chakrabarti: North American Ginseng (Panax quinquefolius) prevents hyperglycemia and associated pancreatic abnormalities in diabetes. J Med Food 16, 587-592 (2013) DOI: 10.1089/jmf.2012.0192
50. L. De Souza, A. Jenkins, J. Sievenpiper, E. Jovanovsk, D. Rahelic, V. Vuksan: Korean red ginseng (Panax ginseng C.A. Meyer) root fractions: differential effects on postprandial glycemia in healthy individuals. J Ethnopharmacol 137, 245-250 (2011) DOI: 10.1016/j.jep.2011.05.015
51. N. Lee, C. Son: Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng. J Acupunct Meridian Stud 4, 85-97 (2011) DOI: 10.1016/S2005-2901(11)60013-7
52. V. Vuksan, M. Sung, J. Sievenpiper, P. Stavro, A. Jenkins, M. Di Buono, K. Lee, L. Leiter, K. Nam, J. Arnason, M. Choi, A. Naeem: Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 1, 46-56 (2008) DOI: 10.1016/j.numecd.2006.04.003
53. P. Ranasinghe, R. Jayawardana, P. Galappathy, G.R. Constantine, N. de Vas Gunawardana, P. Katulanda: Efficacy and safety of true cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 29, 1480-1492 (2012) DOI: 10.1111/j.1464-5491.2012.03718.x
54. C. Ulbricht, E. Seamon, R.C. Windsor, N. Armbruester, J.K. Bryan, D. Costa, N. Giese, J. Gruenwald, R. Iovin, R. Isaac, J.M. Grimes, S. Tanguay-Colucci, W. Weissner, H. Yoon, J. Zhang: An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration. J Diet Suppl 8, 378-454 (2011) DOI: 10.3109/19390211.2011.627783
55. A. Absalan, J. Mohiti-Ardakani, H. Hadinedoushan, M.A. Khalili: Hydro-alcoholic cinnamon extract enhances glucose transporter isotype-4 translocation from intracellular compartments into the cytoplasmic membrane of C2C12 myotubes. Ind J Clin Biochem 27, 351-356 (2012) DOI: 10.1007/s12291-012-0214-y
56. P. Anand, Murali K.Y., V. Tandon, P.S. Murthy, R. Chandra: Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem Biol Interact 186, 72-81 (2010) DOI: 10.1016/j.cbi.2010.03.044
57. S.Y. Soonham, M.K. Samir: Effect of cinnamon on plasma glucose concentration and the regulation of 6-phosphofructo-1-kinase activity from the liver and small intestine of strptozotocin induced diabetic rats. J Biolog Sci 10, 761-766 (2010) DOI: 10.3923/jbs.2010.761.766
58. S. Adisakwattana, O. Lerdsuwankij, U. Poputtachai, A. Minipun, C. Suparpprom: Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal alphaglucosidase and pancreatic alphaamylase. Plant Foods Hum Nutr 66, 143-148 (2011) DOI: 10.1007/s11130-011-0226-4
59. B. Roffey, A. Atwal, S. Kubow: Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3R3-L1 adipose cells. Mol Nutr Food Res 50, 739-745 (2006) DOI: 10.1002/mnfr.200500253
60. Y. Shen, M. Fukushima, Y. Ito, E. Muraki, T. Hosono, T. Seki, T. Ariga: Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotechnol Biochem 74, 2418-2425 (2010) DOI: 10.1271/bbb.100453
61. B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, Y. Sato: Cinnamon extract (traditional herb) potentiates in vivo insulin- regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 62, 139-148 (2003) DOI: 10.1016/S0168-8227(03)00173-6
62. R. Allen, E. Schwartzman, W.L. Baker, C.I. Coleman, O.J. Phung: Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11, 452-459 (2013) DOI: 10.1370/afm.1517
63. H.M. Said: Cell and molecular aspects of human intestinal biotin absorption. J Nutr 139, 158-162 (2009) DOI: 10.3945/jn.108.092023
64. R.J. McMahon: Biotin in metabolism and molecular biology. Annu Rev Nutr 22, 221-239 (2002) DOI: 10.1146/annurev.nutr.22.121101.112819
65. R. Rodirigo-Melendez, J. Zempleni: Regulation of gene expression by biotin. J Nutr Biochem 14, 680-690 (2003) DOI: 10.1016/j.jnutbio.2003.07.001
66. M. Maebashi, Y. Makino, Y Furukawa, K. Ohinata, S. Kimura, T. Sato: Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin diabetes mellitus. J Clin Biochem Nutr 14, 211-218 (1993) DOI: 10.3164/jcbn.14.211
67. J. Chauhan, K. Dakshinamurti: Transcriptional regulation of the glucokinase gene by biotin in starved rats. J Biol Chem 266, 10035-10038 (1991)
68. G. Romero-Navaro, G. Cabrera-Valladares, M.S. German, F.M. Matschinsky, A. Velasquez, J. Wang, C. Fernandez-Mejia: Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotindeficient rats. Endocrinology 140, 4595-4600 (1999)
69. H. Sone, M. Ito, K. Sugiyama, M. Ohneda, M. Maebashi, Y. Furukawa: Biotin enhances glucose-stimulated insulin secretion in the isolated perfused pancreas of the rat. J Nutr Biochem 10, 237-243 (1999) DOI: 10.1016/S0955-2863(99)00003-0
70. L. De La Vega, R.J. Stockert: Regulation of the insulin and asialoglycoprotein receptors via cGMP-dependent protein kinase. Am J Physiol Cell Physiol 279, C2037-C2042 (2000)
71. E. Larrieta, M.L.L. de la Vega-Monroy, P. Vital, A. Aguilera, M.S. German, M. El Hafidi, C. Fernandez-Mejia: Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis. J Nutr Biochem 23, 392-399 (2012) DOI: 10.1016/j.jnutbio.2011.01.003
72. M.F. McCarty: cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for highdose biotin in prevention/treatment of diabetes. Med Hypotheses 66, 323-328 (2006) DOI: 10.1016/j.mehy.2004.04.031
73. L.F. Michael, Z. Wu, R.B. Cheatham, P. Puigserver, G. Adelmant, J.J. Lehman, D.P. Kelly, B.M. Spiegelman: Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional co-activator PGC-1. Proc Natl Acad Sci U S A 98, 3820-3825 (2001) DOI: 10.1073/pnas.061035098
74. G.J. Etgen Jr., D.A. Fryburg, E.M. Gibbs: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46, 1915-1919 (1997) DOI: 10.2337/diab.46.11.1915
75. C. Albarracin, B. Fuqua, J. Geohas, V. Juturu, M.R. Finch, J.R. Komorowski: Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, doubleblind randomized clinical trial. J Cardiometab Syndr 2, 91-97 (2007) DOI: 10.1111/j.1559-4564.2007.06366.x
76. C. Albarracin, B. Fuqua, J.L. Evans, I.D. Goldfine: Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev 24, 41-51 (2008) DOI: 10.1002/dmrr.755
77. K.P. Shay, R.F. Moreau, E.J. Smith, A.R. Smith, T.M. Hagen: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790, 1149-1160 (2009) DOI: 10.1016/j.bbagen.2009.07.026
78. B. Diesel, S. Kulhanek-Heinze, M. Holtje, B. Brandt, H.D. Holtje, A.M. Vollmar, A.K. Kiemer: Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. Biochemistry 46, 2146-2155 (2007) DOI: 10.1021/bi602547m
79. K.J. Cho, H. Moini, H.K. Shon, A.S. Chung, L. Packer: Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem Pharmacol 66, 849-858 (2003) DOI: 10.1016/S0006-2952(03)00395-2
80. V. Saengsirisuwan, F.R. Perez, J.A. Sloniger, T. Maier, E.J. Henriksen: Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats. Am J Physiol Endocrinol Metab 287, E529-E536 (2004) DOI: 10.1152/ajpendo.00013.2004
81. W.J. Lee, K.H. Song, E.H. Koh, J.C. Won, H.S. Kim, H.S. Park, M.S. Kim, S.W. Kim, K.U. Lee, J.Y. Park: Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332, 885-891 (2005) DOI: 10.1016/j.bbrc.2005.05.035
82. J.T. Treebak, S. Glund, A. Deshmukh, D.K. Klein, Y.C. Long, T.E. Jensen, S.B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, T. Wallimann, E.A. Richter, A.V. Chibalin, J.R. Zierath, J.F. Wojtaszewski: AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55, 2051-2058 (2006) DOI: 10.2337/db06-0175
83. K. Paz, R. Hemi, D. LeRoith, A. Karasik, E. Elhanany, H. Kanety, Y. Zick: A molecular basis for insulin resistance: elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272, 29911-29918 (1997) DOI: 10.1074/jbc.272.47.29911
84. R. Pop-Busui, M.J. Stevens, D.M. Raffel, E.A. White, M. Mehta, C.D. Plunkett, M.B. Brown, E.L. Feldman: Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomized controlled trial. Diabetalogia 56, 1835-1844 (2013) DOI: 10.1007/s00125-013-2942-9
85. D. Ziegler, P.A. Low, W.J. Litchy, A.J. Boulton, A.I. Vinik, R. Freeman, R. Samigullin, H. Tritschler, U. Munzel, J. Maus, K. Schütte, P.J. Dyck: Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34, 2054-2060 (2011) DOI: 10.2337/dc11-0503
86. A.M. de Oliveira, P.H. Rondó, L.A. Luzia, F.H. D'Abronzo, V.K. Illison: The effects of lipoic acid and alpha-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, doubleblind, placebo-controlled trial. Diabetes Res Clin Pract 92, 253-260 (2011) DOI: 10.1016/j.diabres.2011.02.010
87. S. Jacob, P. Ruus, R. Hermann, H.J. Tritschler, E. Maerker, W. Renn, H.J. Augustin, G.J. Dietze, K. Rett: Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27, 309-314 (1999) DOI: 10.1016/S0891-5849(99)00089-1
88. S. Jacob, R.S. Streeper, D.L. Fogt, J.Y. Hokama, H.J. Tritschler, G.J. Dietze, E.J. Henriksen: The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45, 1024-1029 (1996) DOI: 10.2337/diab.45.8.1024
89. J. Salmeron, J.E. Manson, M.J. Stampfer, G.A. Colditz, A.L. Wing, W.C. Willett: Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472-477 (1997) DOI: 10.1001/jama.1997.03540300040031
90. W. Willett, J. Manson, S. Liu: Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 76, 274S-280S (2002)
91. P.J. Boyle: Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med 120, S12-S17 (2007) DOI: 10.1016/j.amjmed.2007.07.003
92. A. Ceriello: Hyperglycaemia and the vessel wall: the pathophysiological aspects of the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil 17, S15-S19 (2010) DOI: 10.1097/01.hjr.0000368193.24732.66
93. C. Payne: Complementary and integrative medicine: emerging therapies for diabetes. Part I. Diabetes Spectrum 14, 129-131 (2001) DOI: 10.2337/diaspect.14.3.129
94. G.Y. Yeh, D.M. Eisenberg, R.B. Davis, R.S. Phillips: Complementary and alternative medicine use among patients with diabetes mellitus: results of a national survey. Am J Pub Health 92, 1648-1652 (2002) DOI: 10.2105/AJPH.92.10.1648